Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 197309, 14 pages
http://dx.doi.org/10.1155/2012/197309
Research Article

The Antitumor Activity of Antrodia camphorata in Melanoma Cells: Modulation of Wnt/β-Catenin Signaling Pathways

1Department of Cosmeceutics, College of Pharmacy, China Medical University, Taichung 40402, Taiwan
2Institute of Nutrition, China Medical University, Taichung 40402, Taiwan
3Department of Medical Research, Chi Mei Medical Center, Tainan 710, Taiwan
4Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
5Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan

Received 6 July 2012; Accepted 14 August 2012

Academic Editor: Olumayokun A. Olajide

Copyright © 2012 You-Cheng Hseu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Chien, E. C. Moore, A. S. Lonsdorf et al., “Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 4, pp. 1193–1198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Fatima, N. P. Lee, and J. M. Luk, “Dickkopfs and Wnt/β-catenin signalling in liver cancer,” World Journal of Clinical Oncology, vol. 2, no. 8, pp. 311–325, 2011. View at Publisher · View at Google Scholar
  3. S. Terry, X. Yang, M. W. Chen, F. Vacherot, and R. Buttyan, “Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer,” Journal of Cellular Biochemistry, vol. 99, no. 2, pp. 402–410, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Turashvili, J. Bouchal, G. Burkadze, and Z. Kolar, “Wnt signaling pathway in mammary gland development and carcinogenesis,” Pathobiology, vol. 73, no. 5, pp. 213–223, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Clément, D. M. Jablons, and J. Benhattar, “Targeting the Wnt signaling pathway to treat Barrett's esophagus,” Expert Opinion on Therapeutic Targets, vol. 11, no. 3, pp. 375–389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Mazieres, L. You, B. He et al., “Wnt2 as a new therapeutic target in malignant pleural mesothelioma,” International Journal of Cancer, vol. 117, no. 2, pp. 326–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Fishman, L. Madi, S. Bar-Yehuda, F. Barer, L. Del Valle, and K. Khalili, “Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells,” Oncogene, vol. 21, no. 25, pp. 4060–4064, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. R. S. Tarapore, I. A. Siddiqui, M. Saleem, V. M. Adhami, V. S. Spiegelman, and H. Mukhtar, “Specific targeting of wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol,” Carcinogenesis, vol. 31, no. 10, pp. 1844–1853, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Polakis, “Wnt signaling and cancer,” Cold Spring Harbor Perspectives in Biology, vol. 4, no. 5, 2012. View at Publisher · View at Google Scholar
  10. L. You, B. He, K. Uematsu et al., “Inhibition of Wnt-1 signaling induces apoptosis in β -catenin-deficient mesothelioma cells,” Cancer Research, vol. 64, no. 10, pp. 3474–3478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Zeng, F. Awan, W. Otruba et al., “Wnt'er in liver: expression of Wnt and frizzled genes in mouse,” Hepatology, vol. 45, no. 1, pp. 195–204, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Chen, D. C. Guttridge, Z. You et al., “Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription,” The Journal of Cell Biology, vol. 152, no. 1, pp. 87–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Li, R. Pamukcu, and W. J. Thompson, “β-catenin signaling: therapeutic strategies in oncology,” Cancer Biology & Therapy, vol. 1, no. 6, pp. 621–625, 2002. View at Google Scholar · View at Scopus
  14. B. He, L. You, K. Uematsu et al., “A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells,” Neoplasia, vol. 6, no. 1, pp. 7–14, 2004. View at Google Scholar · View at Scopus
  15. M. Huang, Y. Wang, D. Sun et al., “Identification of genes regulated by Wnt/β-catenin pathway and involved in apoptosis via microarray analysis,” BMC Cancer, vol. 6, article 221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Kulikova, A. Kibardin, N. Gnuchev, G. Georgiev, and S. Larin, “Dual function of Wnts in human cutaneous melanoma,” in Research on Melanoma-A Glimpse into Current Directions and Future Trends, M. Murph, Ed., pp. 243–268, InTech Open Publishing, Rijeka,Croatia, 2011. View at Google Scholar
  17. M. Vaid, R. Prasad, Q. Sun, and S. K. Katiyar, “Silymarin targets β-Catenin signaling in blocking migration/invasion of human melanoma cells,” PLoS ONE, vol. 6, no. 7, Article ID e23000, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. H. H. Luu, R. Zhang, R. C. Haydon et al., “Wnt/β-catenin signaling pathway as novel cancer drug targets,” Current Cancer Drug Targets, vol. 4, no. 8, pp. 653–671, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Zhang, J. P. Gaspard, and D. C. Chung, “Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia,” Cancer Research, vol. 61, no. 16, pp. 6050–6054, 2001. View at Google Scholar · View at Scopus
  20. H. L. Yang, K. J. S. Kumar, and Y. C. Hseu, “Multiple molecular targets of Antrodia camphorata: a suitable candidate for breast cancer chemoprevention,” in Targeting New Pathways and Cell Death in Breast Cancer, R. Aft, Ed., pp. 157–179, InTech Open Publishing, Rijeka, Croatia, 2012. View at Google Scholar
  21. Z. H. Ao, Z. H. Xu, Z. M. Lu, H. Y. Xu, X. M. Zhang, and W. F. Dou, “Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases,” Journal of Ethnopharmacology, vol. 121, no. 2, pp. 194–212, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Geethangili and Y. M. Tzeng, “Review of pharmacological effects of Antrodia camphorata and its bioactive compounds,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 212641, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. C. C. Lee, H. L. Yang, T. D. Way et al., “Inhibition of cell growth and induction of apoptosis by Antrodia camphorata in HER-2/neu-overexpressing breast cancer cells through the induction of ROS, depletion of HER-2/neu, and disruption of the PI3K/Akt signaling pathway,” Evidence Based Complementary and Alternative Medicine, vol. 2012, Article ID 702857, 15 pages, 2012. View at Publisher · View at Google Scholar
  24. H. L. Yang, C. S. Chen, W. H. Chang et al., “Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata,” Cancer Letters, vol. 231, no. 2, pp. 215–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. C. Hseu, S. C. Chen, P. C. Tsai et al., “Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata,” Food and Chemical Toxicology, vol. 45, no. 7, pp. 1107–1115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. C. Hseu, S. C. Chen, H. C. Chen, J. W. Liao, and H. L. Yang, “Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo,” Food and Chemical Toxicology, vol. 46, no. 8, pp. 2680–2688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. H. L. Yang, Y. H. Kuo, C. T. Tsai et al., “Anti-metastatic activities of Antrodia camphorata against human breast cancer cells mediated through suppression of the MAPK signaling pathway,” Food and Chemical Toxicology, vol. 49, no. 1, pp. 290–298, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. C. Hseu, H. C. Huang, and C. Y. Hsiang, “Antrodia camphorata suppresses lipopolysaccharide-induced nuclear factor-κB activation in transgenic mice evaluated by bioluminescence imaging,” Food and Chemical Toxicology, vol. 48, no. 8-9, pp. 2319–2325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. K. I. Takemaru, M. Ohmitsu, and F. Q. Li, “An oncogenic hub: β-catenin as a molecular target for cancer therapeutics,” in Protein-Protein Interactions as New Drug Targets, Hand Book of Experimental Pharmacology, E. Klussmann and J. Scott, Eds., pp. 261–284, Springer, Heidelberg, Germany, 2008. View at Google Scholar
  30. H. Matsubayashi, S. Sese, J. S. Lee et al., “Biochemical characterization of the Drosophila wingless signaling pathway based on RNA interference,” Molecular and Cellular Biology, vol. 24, no. 5, pp. 2012–2024, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. D. N. Syed, F. Afaq, N. Maddodi et al., “Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased mitf levels,” Journal of Investigative Dermatology, vol. 131, no. 6, pp. 1291–1299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Sinnberg, M. Menzel, D. Ewerth et al., “β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance,” PLoS One, vol. 6, no. 8, Article ID e23429, 2011. View at Google Scholar
  33. A. Buque, J. S. Muhialdin, A. Munoz et al., “Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells,” Molecular Cancer, vol. 11, no. 1, p. 25, 2012. View at Publisher · View at Google Scholar
  34. W. E. Damsky Jr., L. E. Rosenbaum, and M. Bosenberg, “Decoding melanoma metastasis,” Cancers, vol. 3, no. 1, pp. 126–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. F. H. Sarkar, Y. Li, Z. Wang, and D. Kong, “The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer,” Cancer and Metastasis Reviews, vol. 29, no. 3, pp. 383–394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Bellei, E. Flori, E. Izzo, V. Maresca, and M. Picardo, “GSK3β inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes,” Cellular Signalling, vol. 20, no. 10, pp. 1750–1761, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Yan, J. Thomas, T. Liu et al., “Induction of melanoma cell apoptosis and inhibition of tumor growth using a cell-permeable survivin antagonist,” Oncogene, vol. 25, no. 52, pp. 6968–6974, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Nakashima, D. Liu, C. L. Huang, M. Ueno, X. Zhang, and H. Yokomise, “Wnt3 gene expression promotes tumor progression in non-small cell lung cancer,” Lung Cancer, vol. 76, no. 2, pp. 228–234, 2012. View at Google Scholar
  39. A. Carnero, “Targeting the cell cycle for cancer therapy,” British Journal of Cancer, vol. 87, no. 2, pp. 129–133, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. C. Hseu, M. S. Lee, C. R. Wu et al., “The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway,” Journal of Agriculture and Food Chemistry, vol. 60, no. 9, pp. 2385–2397, 2012. View at Publisher · View at Google Scholar
  41. G. K. Schwartz and M. A. Shah, “Targeting the cell cycle: a new approach to cancer therapy,” Journal of Clinical Oncology, vol. 23, no. 36, pp. 9408–9421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. M. Abukhdeir and B. H. Park, “p21 and p27: roles in carcinogenesis and drug resistance,” Expert Reviews in Molecular Medicine, vol. 10, article e19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. L. Gartel and A. L. Tyner, “The role of the cyclin-dependent kinase inhibitor p21 in apoptosis,” Molecular Cancer Therapeutics, vol. 1, no. 8, pp. 639–649, 2002. View at Google Scholar · View at Scopus
  44. E. Lin, W. H. Lin, S. Y. Wang et al., “Flavokawain B inhibits growth of human squamous carcinoma cells: involvement of apoptosis and cell cycle dysregulation in vitro and in vivo,” The Journal of Nutritional Biochemistry, vol. 23, no. 4, pp. 368–378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Chowdhury, B. Tharakan, and G. K. Bhat, “Current concepts in apoptosis: the physiological suicide program revisited,” Cellular and Molecular Biology Letters, vol. 11, no. 4, pp. 506–525, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. M. S. Ricci and W. X. Zong, “Chemotherapeutic approaches for targeting cell death pathways,” The Oncologist, vol. 11, no. 4, pp. 342–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. J. A. Sánchez-Alcázar, A. Khodjakov, and E. Schneider, “Anticancer drugs induce increased mitochondrial cytochrome c expression that precedes cell death,” Cancer Research, vol. 61, no. 3, pp. 1038–1044, 2001. View at Google Scholar · View at Scopus
  48. Y. C. Hseu, H. L. Yang, Y. C. Lai, J. G. Lin, G. W. Chen, and Y. H. Chang, “Induction of apoptosis by Antrodia camphorata in human premyelocytic leukemia HL-60 cells,” Nutrition and Cancer, vol. 48, no. 2, pp. 189–197, 2004. View at Google Scholar · View at Scopus
  49. M. Javle and N. J. Curtin, “The role of PARP in DNA repair and its therapeutic exploitation,” British Journal of Cancer, vol. 105, no. 8, pp. 1114–1122, 2011. View at Publisher · View at Google Scholar
  50. P. Shen, J. M. Guenther, L. A. Wanek, and D. L. Morton, “Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?” Annals of Surgical Oncology, vol. 7, no. 2, pp. 114–119, 2000. View at Google Scholar · View at Scopus
  51. J. Homsi, M. Kashani-Sabet, J. L. Messina, and A. Daud, “Cutaneous melanoma: prognostic factors,” Cancer Control, vol. 12, no. 4, pp. 223–229, 2005. View at Google Scholar · View at Scopus
  52. R. Ria, A. Reale, A. Castrovilli et al., “Angiogenesis and progression in human melanoma,” Dermatology Research and Practice, vol. 2010, no. 2010, Article ID 185687, 2010. View at Google Scholar
  53. Y. C. Hseu, W. C. Chang, Y. T. Hseu et al., “Protection of oxidative damage by aqueous extract from Antrodia camphorata mycelia in normal human erythrocytes,” Life Sciences, vol. 71, no. 4, pp. 469–482, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. C. T. Yeh, Y. K. Rao, C. J. Yao et al., “Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells,” Cancer Letters, vol. 285, no. 1, pp. 73–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. T. H. Lee, C. K. Lee, W. L. Tsou, S. Y. Liu, M. T. Kuo, and W. C. Wen, “A new cytotoxic agent from solid-state fermented mycelium of Antrodia camphorata,” Planta Medica, vol. 73, no. 13, pp. 1412–1415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. K. Rao, A. T. H. Wu, M. Geethangili et al., “Identification of antrocin from Antrodia camphorata as a selective and novel class of small molecule inhibitor of Akt/mTOR signaling in metastatic breast cancer MDA-MB-231 cells,” Chemical Research in Toxicology, vol. 24, no. 2, pp. 238–245, 2011. View at Publisher · View at Google Scholar · View at Scopus